Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment
Abstract
Acid-sensitive GOx@MPN@Gel (GOx, luteolin, Fe, MOFs) drives glucose oxidation to fuel enhanced chemodynamic/photodynamic ROS for synergistic cancer therapy.
Fields of Study & Subjects
Photodynamic Therapy Research Studies
Nanoplatforms for cancer theranostics
Click Chemistry and Applications
Publication details
- Journal / source
- Nanoscale Horizons
- Publisher
- Royal Society of Chemistry (RSC)
- Volume
- 11
- Issue
- 9
- Pages
- 2401–2412
- Publication date
- 1 January 2026
- Language
- EN